Key takeaways:
Stelfonta (tigilanol tiglate) is an injection that treats mast cell tumors in dogs.
Surgery is the first-choice treatment for mast cell tumors. But Stelfonta can help when surgery isn’t an option.
Stelfonta treatment will leave an open wound on your dog that may take 4 to 6 weeks to heal.
Mast cell tumors are one of the most common forms of skin cancer in dogs. These tumors require fast treatment because they can be aggressive and spread to other parts of the body.
Stelfonta (tigilanol tiglate) is a relatively new treatment option for canine mast cell tumors. It is primarily used to treat tumors that cannot safely be removed surgically.
Keep reading to learn more about this Stelfonta for dogs.
Common names | Stelfonta (tigilanol tiglate) |
What it treats | Mast cell tumors |
How it comes (forms) | Injection |
Dosage | Determined by a veterinarian |
Common side effects | Open wound |
Stelfonta is a relatively new cancer medication for dogs. It received FDA approval in 2020.
Stelfonta is a protein kinase C activator. This means that it activates an enzyme (a natural substance in the body) called protein kinase C. Because of this, when Stelfonta is injected into a tumor, it causes:
Inflammation of the tumor
Disrupted tumor blood flow
Tumor cell death
These effects can be used to eliminate some mast cell tumors.
Stelfonta is used to treat mast cell tumors in dogs. It is primarily used to manage mast cell tumors that cannot be removed surgically.
The first-choice treatment for mast cell tumors is surgery. But mast cell tumor surgery requires a veterinarian to remove a lot of the tissue around the tumor. This ensures that all tumor cells are completely removed. This is easy on some parts of a dog’s body, like the torso. But removing enough tissue isn’t possible on other parts, like the legs and muzzle.
A firsthand account of Stelfonta (tigilanol tiglate) for dogs: Read how one dog owner treated her pup’s mast cell tumor using Stelfonta — and why she says it was worth it.
Mast cell tumors: If your dog was diagnosed with a mast cell tumor, here’s everything you need to know about this common skin cancer.
Other dog skin cancers: Mast cell tumors are just one type of skin cancer that can affect dogs. Here are some other common ones your veterinarian may want to rule out.
When a dog’s mast cell tumor is in a location where it’s difficult to remove enough tissue, a veterinarian may suggest Stelfonta. In one study, Stelfonta successfully removed mast cell tumors in about 75% of dogs with a single treatment.
Stelfonta is given to dogs as an injection at the veterinarian’s office.
Two days before your dog receives the injection, you will give them pretreatment medications at home. These medications typically include:
A steroid, such as prednisone
An antihistamine, like diphenhydramine
Pretreatment medications reduce the risk of side effects associated with Stelfonta treatment.
After 2 days of pretreatment, you will take your dog to the veterinarian for the Stelfonta injection. At the appointment, your veterinarian will do the following:
Shave the hair from the tumor and surrounding area
Measure the tumor and calculate its volume
Determine the correct Stelfonta dosage, based on the tumor’s size
Inject Stelfonta directly into your dog’s tumor
Apply a bandage
Some dogs need sedation for a Stelfonta injection. Your dog must hold very still so that all of the medication is injected directly into their tumor.
Your dog may be sent home with an e-collar (cone) after receiving Stelfonta. This will keep them from licking their tumor and wound in the coming days and weeks.
After your dog receives the Stelfonta injection, you will continue their steroid and antihistamine treatment for 1 week. Your veterinarian will also prescribe them an antacid, like famotidine. These post-treatment medications reduce the risk of side effects associated with Stelfonta.
Some dogs need only one Stelfonta injection. Other dogs may need more than one.
The most common side effect of Stelfonta in dogs is an open, draining wound at the mast cell tumor site. This wound is a result of the tumor dying, so it means the medication is working. It usually forms between 3 to 7 days after an injection and is a normal part of Stelfonta treatment.
The wound may initially be larger than the tumor. But it will shrink over time. The healing process usually takes 4 to 6 weeks. Stelfonta’s website provides examples of post-treatment wounds at different stages of healing if that’s helpful for you to see.
Your veterinarian will prepare you for what to expect during treatment. They will also help you monitor your dog’s progress.
Less common side effects that may occur with Stelfonta include:
Swelling at the injection site
Bruising at the injection site
Pain and discomfort
Limping (when tumors on the leg are treated)
Infection of the open wound
Enlarged lymph nodes
Lack of energy
If you notice any concerning side effects, talk to your veterinarian.
The most serious risk of Stelfonta for dogs occurs when the mast cell tumor dies. As a mast cell tumor dies, it releases inflammatory signals that can cause negative effects in dogs. This process is called degranulation.
You will give your dog medications before and after their Stelfonta injection. The medications should help protect your dog from these inflammatory signals. But in rare cases, mast cell tumor degranulation can cause:
Vomiting
Weight loss
Pale gums
Collapse (shock)
Stomach ulcers
If your dog becomes seriously ill after receiving Stelfonta, seek veterinary care immediately. If your veterinarian’s office is closed, contact an emergency pet clinic. Immediate treatment may be needed.
At this time, there are no known interactions between Stelfonta and other medications. But Stelfonta is a relatively new treatment. We may discover medication interactions as it’s used to treat more dogs.
To minimize the risk of interactions, make sure your veterinarian knows about any medications your dog is taking. This includes:
Prescription medications
Over-the-counter medications
Nutritional supplements
Knowing your dog’s full medication history can help your veterinarian reduce the risk of interactions.
Stelfonta is given as a one-time injection in a veterinary clinic. If you miss your dog’s appointment, your visit will be rescheduled for another day or time.
Give your dog their pretreatment medications as directed. If you miss a dose of one of these medications in the days leading up to your dog’s Stelfonta injection, contact your veterinarian. They may postpone your dog’s treatment.
Your dog’s post-treatment medications will also help reduce side effects. If you miss a dose of your dog’s steroid, antihistamine, or antacid after their injection, give them the medication as soon as you remember. Then, wait the recommended amount of time to give them their next dose. Do not give your dog a double dose of medication.
Surgical removal is the first-choice treatment for mast cell tumors in dogs. But surgery isn’t an option for all dogs. Stelfonta (tigilanol tiglate) offers a safe and effective alternative for treating mast cell tumors in these cases.
Stelfonta is injected by a veterinarian directly into a dog’s mast cell tumor, causing the tumor to die. This treatment leaves an open wound, which heals in the weeks following the injection. Serious side effects of Stelfonta are rare, especially when a dog is given pretreatment and post-treatment medications as directed.
If you have questions about Stelfonta treatment for mast cell tumors, consult your veterinarian.
Brooks, W. (2023). Mast cell tumors in dogs and cats. Veterinary Partner.
De Ridder, T. R., et al. (2020). Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate (EBC-46). Journal of Veterinary Internal Medicine.
Michigan State University Veterinary Diagnostic Laboratory. (n.d.). Canine mast cell tumors.
North Carolina State University Veterinary Hospital. (n.d.). Medical oncology: Stelfonta.
Ryan Veterinary Hospital. (n.d.). Mast cell tumors in dogs. University of Pennsylvania.
Stelfonta. (n.d.). Pictures of mast cell tumors on dogs.
U.S. Food and Drug Administration. (2020). FDA approves first intratumoral injection to treat non-metastatic mast cell tumors in dogs.
Virbac. (2020). Stelfonta (tigilanol tiglate injection) [package insert].